Judith M. Versluis
Amsterdam, NH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
Clinical, pathological and molecular characteristics of patients with disease recurrence despite pathologic response to neoadjuvant ipilimumab plus nivolumab in stage III melanoma.
Journal: Communications medicine
Published: January 31, 2025
Impact of personalized response-directed surgery and adjuvant therapy on survival after neoadjuvant immunotherapy in stage III melanoma: Comparison of 3-year data from PRADO and OpACIN-neo.
Journal: European journal of cancer (Oxford, England : 1990)
Published: September 10, 2024
Interferon-gamma signature as prognostic and predictive marker in macroscopic stage III melanoma.
Journal: Journal for immunotherapy of cancer
Published: March 25, 2024
The features and management of acquired resistance to PD1-based therapy in metastatic melanoma.
Journal: European journal of cancer (Oxford, England : 1990)
Published: August 27, 2023
IMPemBra: a phase 2 study comparing pembrolizumab with intermittent/short-term dual MAPK pathway inhibition plus pembrolizumab in patients with melanoma harboring the BRAFV600 mutation.
Journal: Journal for immunotherapy of cancer
Published: June 18, 2023
Personalizing neoadjuvant immune-checkpoint inhibition in patients with melanoma.
Journal: Nature reviews. Clinical oncology
Published: March 28, 2023
Systemic LRG1 Expression in Melanoma is Associated with Disease Progression and Recurrence.
Journal: Cancer research communications
Published: January 31, 2023
IFN-γ signature enables selection of neoadjuvant treatment in patients with stage III melanoma.
Journal: The Journal of experimental medicine
Published: November 14, 2022
Dataset of a retrospective multicenter cohort study on characteristics of immune checkpoint inhibitor-induced encephalitis and comparison with HSV-1 and anti-LGI1 encephalitis.
Journal: Data in brief
Published: August 18, 2022
Efficacy of anti-PD-1 and ipilimumab alone or in combination in acral melanoma.
Journal: Journal for immunotherapy of cancer
Published: May 31, 2022
Characteristics of immune checkpoint inhibitor-induced encephalitis and comparison with HSV-1 and anti-LGI1 encephalitis: A retrospective multicentre cohort study.
Journal: European journal of cancer (Oxford, England : 1990)
Published: May 20, 2022
Last Updated: 09/26/2026